Rational combination of mTOR and Aurora kinase A inhibition in preclinical models of triple-negative breast cancer

被引：0
|
作者：
Diamond, Jennifer R. [1 ]
Orth, James D. [2 ]
Ionkina, Anastasia [3 ]
Dailey, Kyrie [1 ]
Pitts, Todd M. [1 ]
Capasso, Anna [1 ]
Marcus, Joshua M. [2 ]
Burke, Russell T. [2 ]
Davis, Sarah L. [1 ]
Kim, Jiyhe [1 ]
Tan, Aik-Choon [1 ]
Eckhardt, Sue G. [4 ]
Tentler, John J. [1 ]
机构：
[1] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Boulder, CO 80309 USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B175
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rational combination of Wee1 and BCL-2 inhibition in preclinical models of triple-negative breast cancer
    Simmons, D. M.
    Tse, T. E.
    Dailey, K.
    Hartman, S. J.
    Bagsby, S.
    Pitts, T. M.
    Tentler, J. J.
    Diamond, J. R.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [2] Role of mTOR inhibition in triple-negative breast cancer
    Massihnia, Daniela
    Bronte, Giuseppe
    Castiglia, Marta
    Barraco, Nadia
    Cangemi, Antonina
    Perez, Alessandro
    Fanale, Daniele
    Pantuso, Gianni
    Vieni, Salvatore
    Calo, Valentina
    Rolfo, Christian D.
    Bazan, Viviana
    Russo, Antonio
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
    Skov, Natascha
    Alves, Carla L.
    Ehmsen, Sidse
    Ditzel, Henrik J.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [4] Rational combination therapy against triple-negative breast cancer
    Al-Ejeh, F.
    Miranda, M.
    Simpson, P. T.
    Chenevix-Trench, G.
    Lakhani, S. R.
    Khanna, K. K.
    [J]. CANCER RESEARCH, 2012, 72
  • [5] Aurora A kinase activates YAP signaling in triple-negative breast cancer
    S-S Chang
    H Yamaguchi
    W Xia
    S-O Lim
    Y Khotskaya
    Y Wu
    W-C Chang
    Q Liu
    M-C Hung
    [J]. Oncogene, 2017, 36 : 1265 - 1275
  • [6] Aurora A kinase activates YAP signaling in triple-negative breast cancer
    Chang, S-S
    Yamaguchi, H.
    Xia, W.
    Lim, S-O
    Khotskaya, Y.
    Wu, Y.
    Chang, W-C
    Liu, Q.
    Hung, M-C
    [J]. ONCOGENE, 2017, 36 (09) : 1265 - 1275
  • [7] Preclinical Efficacy of the Combination of Met and Src Family Kinase Inhibitors in Triple-Negative Breast Cancer.
    Gartner, E. M.
    Kim, E. M. H.
    Choi, L.
    Boerner, J.
    [J]. CANCER RESEARCH, 2011, 71
  • [8] Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
    Jichao He
    Ronan P. McLaughlin
    Vera van der Noord
    John A. Foekens
    John W. M. Martens
    Gerard van Westen
    Yinghui Zhang
    Bob van de Water
    [J]. Breast Cancer Research and Treatment, 2019, 178 : 263 - 274
  • [9] Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
    He, Jichao
    McLaughlin, Ronan P.
    van der Noord, Vera
    Foekens, John A.
    Martens, John W. M.
    van Westen, Gerard
    Zhang, Yinghui
    van de Water, Bob
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 263 - 274
  • [10] The Aurora A kinase inhibitor MLN8237 in combination with docetaxel induces synergistic antitumor activity in triple-negative breast cancer xenograft models
    Zhang, M.
    Huck, J. J.
    Hyer, M. L.
    Kannan, K.
    Stroud, S.
    Ecsedy, J. A.
    Manfredi, M. G.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 32 - 32
12345